June 19, 2019 / 11:31 PM / a month ago

3rd Circuit dismisses whistleblower case by former Medco executive

A federal appeals court has upheld the dismissal of a whistleblower lawsuit alleging pharmacy benefit manager Medco Health Solutions Inc took kickbacks from AstraZeneca plc in exchange for favoring its drugs including the acid-reflux medication Nexium.

The 3rd U.S. Circuit Court of Appeals in Philadelphia ruled on Tuesday that former Medco executive Paul Denis could not avoid a ban under the False Claims Act (FCA) on pursuing claims that have been previously publicly disclosed and raised in earlier cases.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2WU0sBk

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below